Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Ward

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1993
Intrathecal administration of interleukin-2 for meningeal carcinomatosis due to malignant melanoma: sequential evaluation of intracranial pressure, cerebrospinal fluid cytology, and cytokine inductionW E Samlowski, K J Park, R E Galinsky, et al.
British Journal of Cancer|April 18, 2013
The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs)H A Rogers, J H Ward, S Miller, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Hypoprothrombinemia associated with interleukin-2 therapy: correction with vitamin KG R Birchfield, G M Rodgers, K W Girodias, et al.
The Western Journal of Medicine|September 1, 1991
Cardiomyopathy associated with high-dose interleukin-2 therapyA C Beck, J H Ward, E H Hammond, et al.
Arthritis and Rheumatism|February 1, 1996
Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two casesT R Bachman, A D Sawitzke, S L Perkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Hypocholesterolemia in patients treated with recombinant interleukin-2: appearance of remnant-like lipoproteinsD E Wilson, G R Birchfield, J S Hejazi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1991
Reduction of testosterone synthesis after high dose interleukin-2 therapy of metastatic cancerA W Meikle, J C Cardoso de Sousa, J H Ward, et al.
American Journal of Clinical Pathology|February 1, 1991
Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancerC J Marshall, G B Schumann, J H Ward, et al.
Hematology/Oncology Clinics of North America|January 15, 1999
Models for early chemoprevention trials in breast cancerC J Fabian, B F Kimler, R M Elledge, et al.
American Journal of Human Genetics|January 1, 1985
Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III geneS C Bock, J F Harris, C E Schwartz, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1993
Intrathecal administration of interleukin-2 for meningeal carcinomatosis due to malignant melanoma: sequential evaluation of intracranial pressure, cerebrospinal fluid cytology, and cytokine inductionW E Samlowski, K J Park, R E Galinsky, et al.
British Journal of Cancer|April 18, 2013
The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs)H A Rogers, J H Ward, S Miller, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Hypoprothrombinemia associated with interleukin-2 therapy: correction with vitamin KG R Birchfield, G M Rodgers, K W Girodias, et al.
The Western Journal of Medicine|September 1, 1991
Cardiomyopathy associated with high-dose interleukin-2 therapyA C Beck, J H Ward, E H Hammond, et al.
Arthritis and Rheumatism|February 1, 1996
Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two casesT R Bachman, A D Sawitzke, S L Perkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Hypocholesterolemia in patients treated with recombinant interleukin-2: appearance of remnant-like lipoproteinsD E Wilson, G R Birchfield, J S Hejazi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1991
Reduction of testosterone synthesis after high dose interleukin-2 therapy of metastatic cancerA W Meikle, J C Cardoso de Sousa, J H Ward, et al.
American Journal of Clinical Pathology|February 1, 1991
Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancerC J Marshall, G B Schumann, J H Ward, et al.
Hematology/Oncology Clinics of North America|January 15, 1999
Models for early chemoprevention trials in breast cancerC J Fabian, B F Kimler, R M Elledge, et al.
American Journal of Human Genetics|January 1, 1985
Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III geneS C Bock, J F Harris, C E Schwartz, et al.
Pageof 7